Free Trial

Celldex Therapeutics (CLDX) SEC Filings & 10K Form

Celldex Therapeutics logo
$20.32 -0.46 (-2.21%)
As of 12:12 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Celldex Therapeutics SEC Filings

DateFilerForm TypeView
02/27/2025
3:01 PM
Celldex Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:16 PM
Celldex Therapeutics (Subject)
Kynam Capital Management, LP (Filed by)
Form SCHEDULE 13G/A
02/14/2025
8:44 AM
Celldex Therapeutics (Subject)
Form SCHEDULE 13G
02/12/2025
8:28 AM
Celldex Therapeutics (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
11/14/2024
6:47 PM
Celldex Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
11/14/2024
11:18 AM
Celldex Therapeutics (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Form SC 13G/A
11/14/2024
5:12 AM
Celldex Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
11/13/2024
5:00 PM
Celldex Therapeutics (Subject)
Polar Capital Holdings Plc (Filed by)
Form SC 13G/A
11/12/2024
8:55 AM
Celldex Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
11/08/2024
9:52 AM
Celldex Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/06/2024
3:06 PM
Celldex Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/14/2024
4:34 PM
Celldex Therapeutics (Subject)
Crowley Elizabeth (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
4:12 PM
Celldex Therapeutics (Subject)
Martin Samuel Bates (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
7:00 AM
Celldex Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
3:05 PM
Celldex Therapeutics (Issuer)
Young Diane C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:23 PM
Celldex Therapeutics (Subject)
Young Diane C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
4:51 PM
Celldex Therapeutics (Subject)
Jimenez Freddy A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
4:14 PM
Celldex Therapeutics (Subject)
Wright Richard M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2024
5:01 PM
Celldex Therapeutics (Subject)
Martin Samuel Bates (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2024
5:05 PM
Cavanaugh Sarah (Reporting)
Celldex Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2024
4:47 PM
Celldex Therapeutics (Subject)
Crowley Elizabeth (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2024
2:20 PM
Celldex Therapeutics (Subject)
Heath-Chiozzi Margo (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/25/2024
7:00 AM
Celldex Therapeutics (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:CLDX) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners